
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CIPLc1:NS | NSE | INR | Delayed | |
CIPLc2:NS | NSE | INR | Delayed | |
CIPLc3:NS | NSE | INR | Delayed |
On Wednesday, Citi has revised its price target for Cipla Ltd (CIPLA:IN), a leading pharmaceutical company, to INR 1,830 from INR 1,870. Despite the reduction, the firm continues to recommend a Buy...
On Wednesday, HSBC maintained a Buy rating on Cipla Ltd. (CIPLA:IN) but reduced the price target to INR1,755.00 from the previous INR1,890.00. The adjustment follows the company's second-quarter...
On Wednesday, JPMorgan revised its price target for Cipla Ltd. (CIPLA:IN), a leading pharmaceutical company, reducing it to INR1,600 from the previous INR1,630. Despite this adjustment, the firm...
On Wednesday, the pharmaceutical company Cipla Ltd. (CIPLA:IN) stock maintained its Hold rating with a consistent price target of INR1,580.00, as per CLSA. The firm's analysis points to subdued...
On Wednesday, Investec maintained a Buy rating on Cipla Ltd. (CIPLA:IN) but reduced the stock's price target from INR1,900.00 to INR1,800.00. The adjustment reflects a mix of both cautious and...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review